drug-susceptibility-test | Media Room

Tagged drug-susceptibility-test

Press Release Mar 3, 2022

OliLux Biosciences Kickstarts a Partnership With the UCSF Center for Tuberculosis and the Rapid Research in Diagnostics Development (R2D2) for TB Network

OliLux Biosciences is partnering with the R2D2 TB Network and the UCSF Center for Tuberculosis to clinically evaluate and advance its novel rapid detection technology for drug-resistant tuberculosis.

First
Prev

Next
Last